Back to Search
MUHAMMED SAIF, MD
MD
Addiction Medicine (Psychiatry & Neurology) Physician
NPI: 1396276697IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
63943(NY)
Addiction Medicine (Psychiatry & Neurology) PhysicianPrimary
Psychiatry & Neurology — Addiction Medicine
Code: 2084A0401X
297803(NY)
CMS Specialties
PrimaryPSYCHIATRY
Education
ALBANY MEDICAL COLLEGE OF UNION UNIVERSITY
Class of 2017
Research & Publications (20)
Prognostication of pancreatic adenocarcinoma by expression of thymidine phosphorylase/dihydropyrimidine dehydrogenase ratio and its correlation with survival.
PMID 19663627·Expert Opin Drug Saf·2009
8-other
Oxaliplatin-induced hyperexcitability syndrome in a patient with pancreatic cancer.
PMID 19581758·JOP·2009
5-case
Adjuvant treatment of pancreatic cancer in 2009: where are we? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
PMID 19581737·JOP·2009
6-review
New developments in the treatment of locally advanced pancreatic cancer. Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
PMID 19581736·JOP·2009
8-other
Any progress in the management of advanced pancreatic cancer? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
PMID 19581735·JOP·2009
8-other
Pharmacogenetics in pancreatic cancer. Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
PMID 19581734·JOP·2009
8-other
Biomarkers for early detection and screening in pancreatic cancer. Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
PMID 19581733·JOP·2009
8-other
Recurrent cutaneous toxic erythema induced by gemcitabine in a patient with pancreatic cancer.
PMID 19527102·Cutan Ocul Toxicol·2009
5-case
Severe cutaneous reaction to cetuximab with possible association with the use of over-the-counter skin care products in a patient with oropharyngeal cancer.
PMID 19514925·Cutan Ocul Toxicol·2009
5-case
Thrombotic microangiopathy associated with gemcitabine: rare but real.
PMID 19505260·Expert Opin Drug Saf·2009
5-case
Staphylococcus aureus bacteremia related with erlotinib skin toxicity in a patient with pancreatic cancer.
PMID 19454833·JOP·2009
5-case
Combining epidermal growth factor receptor inhibitors and radiation therapy in pancreatic cancer: small step or giant leap?
PMID 19454812·JOP·2009
6-review
Prolonged survival in a patient with BRCA2 associated metastatic pancreatic cancer after exposure to camptothecin: a case report and review of literature.
PMID 19433978·Anticancer Drugs·2009
5-case
Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol.
PMID 19423504·Clin Colorectal Cancer·2009
8-other
Successful desensitization with cetuximab after an infusion reaction to panitumumab in patients with metastatic colorectal cancer.
PMID 19415280·Cancer Chemother Pharmacol·2009
5-case
Management of infusion reactions in clinical trials and beyond: the US and EU perspectives.
PMID 19385163·Oncology (Williston Park)·2009
6-review
Is there a palliative benefit of gemcitabine plus fluoropyrimidines in patients with refractory colorectal cancer? A review of the literature previously presented: poster at the 2008 Gastrointestinal Cancer Symposium (Abstract No. 512).
PMID 19678797·Expert Opin Investig Drugs·2009
6-review
Disparities in colorectal cancer in African-Americans vs Whites: before and after diagnosis.
PMID 19673013·World J Gastroenterol·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 47 NEW SCOTLAND AVE
ALBANY, NY 12208 - Phone
- (518) 262-5756
Quick Facts
- NPI
- 1396276697
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile